Location History:
- Montreal, FR (2015)
- Lachine, CA (2019)
- Montreal, CA (2016 - 2024)
Company Filing History:
15 out of 24 
4 out of 7 
3 out of 1,206 
Years Active: 2015-2025
Title: **The Innovative Mind of Stephane Ciblat: A Pioneer in Cancer Research Patents**
Introduction
Stephane Ciblat, based in Montreal, CA, is a prominent inventor known for his significant contributions to the field of cancer research through his innovative inventions and extensive patent portfolio. With a remarkable total of 31 patents to his name, Ciblat’s work focuses primarily on therapeutic approaches aimed at treating hyperproliferative diseases, including various forms of cancer.
Latest Patents
Among Ciblat’s most recent patents is a groundbreaking solution involving inhibitors of cyclin-dependent kinase 7 (CDK7). This patent outlines novel compositions, including compounds of Formula (I) or (Ia), with the potential to treat or prevent proliferative diseases such as cancer. The application emphasizes the administration of these compounds to inhibit CDK7 and induce apoptosis in tumor cells, offering promising avenues for cancer treatment.
Another notable patent addresses methods for treating hyperproliferative disorders. This invention discusses techniques for arresting the cell cycle in cancer cells and inhibiting glutathione synthesis, highlighting compounds particularly effective against cancers with a mutant KRAS gene. These inventions have the potential to advance therapeutic strategies for managing and combating cancer more effectively.
Career Highlights
Ciblat’s professional journey includes key roles at notable companies in the pharmaceutical sector. He has contributed his expertise to Syros Pharmaceuticals, Inc. and Bantam Pharmaceutical, LLC, where his work has significantly influenced cancer treatment innovations. His efforts in these positions have solidified his reputation as a leading inventor in the field of pharmaceuticals, particularly in oncology.
Collaborations
Throughout his career, Stephane Ciblat has worked alongside talented professionals, including Jason J Marineau and Kevin Sprott. These collaborations have enhanced his research capabilities and broadened the scope of his innovations, enabling further advancements in cancer therapies and treatments.
Conclusion
With 31 patents to his name, Stephane Ciblat exemplifies a dedicated and innovative mind in the realm of cancer research. His contributions continue to pave the way for new therapeutic approaches, showcasing the importance of collaboration and inventive spirit in addressing complex health challenges. As research and development progress, Ciblat’s work holds promise for significant breakthroughs in the fight against cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.